Impaired Fasting Glucose in Cystic Fibrosis
نویسندگان
چکیده
منابع مشابه
Impaired Fasting Glucose in Cystic Fibrosis
OBJECTIVE While glucose tolerance abnormalities are common in cystic fibrosis (CF), impaired fasting glucose (IFG) has scarcely been explored. No studies have examined the relation between IFG and clinical status. RESEARCH DESIGN AND METHODS Data were retrieved from the University of Minnesota CF database on oral glucose tolerance tests (OGTTs) performed in 1996-2005. Subjects were identified...
متن کاملNew criteria for impaired fasting glucose and screening for diabetes in cystic fibrosis.
Cystic fibrosis-related diabetes mellitus (CFRD) is the most frequent comorbidity in cystic fibrosis. Its clinical relevance is stressed by the association with increased mortality, and decreased pulmonary and nutritional status. An annual oral glucose tolerance test (OGTT) is recommended as a screening test for CFRD, but this is often not realised because of its time- and resource-consuming na...
متن کاملPrevalence of diabetes, impaired fasting glucose and impaired glucose tolerance in patients with thalassemia major in Iran: A meta-analysis
Background: This study aimed to investigate the prevalence of diabetes, impaired fasting glucose (IFG) and impaired glucose tolerance (IGT) in Iranian patients with thalassemia major. Methods: The current study has been conducted based on PRISMA guideline. To obtain the documents, Persian and English scientific databases such as Magiran, Iranmedex, SID, Medlib, IranDoc, Scopus, PubMed, Scien...
متن کاملImpaired glucose tolerance, impaired fasting glucose and cardiovascular risk.
To the Editor: Tamita et al reported that abnormal glucose tolerance in patients with acute myocardial infarction (AMI) is a major risk factor for future cardiovascular events and might critically distinguish high-risk individuals.1 The cardiovascular event-free survival rate in the impaired glucose tolerance (IGT) group and the group with newly diagnosed diabetes were 73% and 67%, respectively...
متن کاملImpaired fasting glucose and impaired glucose tolerance: implications for care.
T ype 2 diabetes is now epidemic. In the U.S., there has been a 61% increase in incidence between 1990 and 2001 (1). There are currently 1.5 million new cases per year, and the prevalence in 2005 was almost 21 million (2). The epidemic has affected developed and developing countries alike, and the worldwide prevalence of diabetes is projected to increase dramatically by 2025 (3). The increase i...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Diabetes Care
سال: 2010
ISSN: 0149-5992,1935-5548
DOI: 10.2337/dc10-0613